Canada In Guyana, elected officials oppose a therapeutic trial against the coronavirus on their territory
Coronavirus. Elected officials of Guyana refuse a therapeutic trial against the Covid-19
© Jody Amiet / AFP Rodolphe Alexandre, president of the territorial community of Guyana, during a meeting on June 22. The president of the territorial community of Guyana, Rodolphe Alexandre, and the two LREM senators of this territory "demanded", this Tuesday, June 30, 2020, that the therapeutic trial conducted by Professor Karine Lacombe, consisting of injecting patients suffering from Covid-19 plasma from cured patients, "does not take place in Guyana".
In Guyana, voices are raised against a therapeutic trial, the inhabitants not wanting to serve as “guinea pigs”EPIDEMIC - In French Guiana, voices are raised against a therapeutic trial, the inhabitants not wanting to serve as "guinea pigs"
"It is not welcome and we asked the prefect to make all the arrangements for that it will not be welcomed in, ”declared after a meeting , the president of the territorial community of Guyana, surrounded by senators Antoine Karam and Geoges Patient.
LIVE Coronavirus: It's back to school for kindergarten, elementary and middle school students this Monday ...
Follow the events linked to the coronavirus epidemic live with us, as many students head back to the school Monday © Suliane FAVENNEC / AFP Schoolchildren in Papeete, Tahiti (illustration image). LIVE - Follow us live with the events linked to the coronavirus epidemic, as many students return to school this Monday THE ESSENTIALS France recorded seven additional deaths linked to Covid-19 in 24 hours, according to the balance sheet published Sunday evening by Santé publique France.
"Elle" is Karine Lacombe, head of infectious diseases at the Saint-Antoine hospital in Paris, non grata in Guyana where she had to go foron patients suffering from .
▶ ️Karine- La1ere.fr (@ la1ere) , head of service at the APHP is not "welcome" in , according to Rodolphe Alexandre and the two senators (Antoine Karam and Geoges Patient), to set up trials therapeutic. They told Prefect Marc Del Grande.
The elected officials therefore "demanded" Tuesday that the therapeutic trial, which consists of injecting patients with Covid-19patients containing antibodies against the coronavirus, "does not take place in French Guiana". Already underway in mainland France, it was to be extended to Guyana and Mayotte. This has attracted much criticism, with some Guyanese refusing to be "guinea pigs".
Covid-19: does the increase in the "R" in five regions mark a renewed epidemic?
The "reproduction rate", an indicator that received much media attention at the height of the pandemic, can only be interpreted in the light of other epidemic data. The situation can thus be brought under control in territories where the reproduction rate seems high, and remain worrying in regions where it remains low. Question asked on 06/23/2020 In recent days, many media have reported an increase in the “reproduction rate” of Covid-19 in several French regions.
Lack of patients
"Where does this unilateral idea come from that Guyanese figures would justify the installation of a therapeutic center in place of hexagonal France? Asked Gabriel Gabriel Serville in a letter to the director of the Guyana Regional Agency. The latter recalls that on June 29, the territory had "only 120 hospitalizations, including 19 in intensive care", and 15 deaths since the beginning of the epidemic, while the metropolis still counted on June 26 "8.886 people hospitalized and 634 in intensive care ”.
Launched on April 7 by the French Blood Establishment (EFS), the Public Assistance-Hospitals of Paris (AP-HP) and Inserm, 200 cured patients were to be sampled in Ile-de-France, in the Grand -Is and in Bourgogne-Franche-Comté, while the trial was to include 120 patients in the acute phase of Covid-19: 60 receiving plasma and 60, a placebo.
A figure not reached, because when the trial was launched in early April "we were already in the phase of deceleration of the epidemic," said Karine Lacombe. Many patients who arrived at the hospital no longer met "the inclusion criteria for the plasma test."
Coronavirus in the United States: Anthony Fauci worried about the resumption of the epidemic .
© POOL / GETTY IMAGES NORTH AMERICA / Getty Images via AFP Doctor Anthony Faucy, director of the National Institute for Allergies and Diseases infectious, testifies before a committee of the congress, in Washington on June 23, 2020. The coronavirus resumes its progression in the United States and the situation is worrying. This was explained by three senior health officials on Tuesday, June 23, before Congress in Washington.